Curnutte John T 4
4 · Orchard Therapeutics plc · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Curnutte John T
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-17+35,000→ 35,000 totalExercise: $7.81Exp: 2030-06-16→ Ordinary Shares (35,000 underlying)
Footnotes (2)
- [F1]All of the shares subject to this option vest upon the earlier to occur of June 17, 2021 or the date of the 2021 Annual General Meeting of the Company.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.